Cure My Disease

Don't miss your cure!

 Log in / Sign up

Timing of scalp block may improve recovery in brain tumor surgery

NCT ID NCT07043621

Symptom relief Sponsor: Sakarya University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study compares two different times to give a scalp block—a numbing injection to the scalp—during brain tumor surgery. One group receives the block before the head is pinned in place, the other just before waking up. Researchers will measure recovery quality, pain, and heart rate changes in 60 adults aged 18 to 80 undergoing supratentorial tumor craniotomy.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
bupivacaine
What this could lead to
If successful, this could help doctors choose the best time for a scalp block to improve patient comfort and recovery after brain tumor surgery.
What could go wrong
This is a small, early-stage study with only 60 participants, so results may not apply to all patients. The timing of the block may not significantly change recovery outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Jul 2025

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged between 18 and 80 years. * Scheduled for elective supratentorial tumor craniotomy under general anesthesia * ASA physical status classification I to III. * Glasgow Coma Scale (GCS) score of 15 at the time of emergence from anesthesia. * Provide informed consent to participate in the study. Exclusion Criteria: * Chronic use of analgesic medications prior to surgery. * Glasgow Coma Scale (GCS) score below 15 postoperatively. * Allergy or hypersensitivity to local anesthetics or opioids used in the study. * Contraindications for scalp block or patient-controlled analgesia. * Patients with severe hepatic, renal, or cardiac dysfunction. * Patients unable to comprehend or complete the QoR-40 questionnaire.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Craniotomy surgery are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia Pain, Postoperative supratentorial cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Craniotomy surgery Qor-40 Regional anesthesia Scalp block

Contacts and locations

Locations

  • Sakarya University Training and Research Hospital

    Adapazarı, Sakarya, 54290, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.